New Inquiries: 201-634-5339
Our Current Patients: Click for directory
Home > News > Fusion Guided Biopsy: Diagnosing Prostate Cancer with Pinpoint Accuracy

News

Font ++ Click to Print

Fusion Guided Biopsy: Diagnosing Prostate Cancer with Pinpoint Accuracy

9/13/2017
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.
 
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting 10prostate cancer. It’s called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.
 
“This targeted MRI/ultrasound biopsy is poised to become a new standard in prostate cancer screening,” explains Howard Frey, M.D., Medical Director, The Urologic Oncology Center, Valley-Mount Sinai Comprehensive Cancer Care. “The advanced technology will help us to more accurately diagnosis prostate cancer, which is the most common cancer among men after skin cancer.”
 
The UroNav Fusion Biopsy System fuses pre-biopsy MRI images of the prostate with ultrasound-guided biopsy images in real time to target suspicious areas for biopsy. This allows for a much more effective and precise prostate biopsy than the standard biopsy. “Prostate cancer can be hard to detect, because patients often do not have symptoms at the time of diagnosis. Deciding what to do about prostate cancer can be challenging, continues Dr. Frey. “It is important to distinguish between aggressive, potentially lethal prostate tumors, and those that are indolent and not life-threatening.”
 
In a standard biopsy, the tissue sampling is done via ultrasound, but there are no targeted areas.  This can pose an issue if the prostate is enlarged because random sampling without a target can miss an aggressive tumor, but find inconsequential non-aggressive prostate cancer that does not require treatment.  
 
Fusion Biopsy greatly improves on the standard technique. First, a prostate MRI is obtained.  If a suspicious area is identified, the result is fused with the live prostate ultrasound providing a target to biopsy.  Thus a directed biopsy is obtained and is more likely to show an intermediate to aggressive cancer.  The biopsy results are then utilized to guide patients in selecting an appropriate treatment modality.
 
About Valley-Mount Sinai Comprehensive Cancer Care’s Urologic Oncology Center
 
Valley-Mount Sinai Comprehensive Cancer Care offers a multidisciplinary Urologic Oncology Center, a unique program that serves as a one-stop, complete resource for patients who have prostate and other urologic cancers. Patients at The Valley Hospital's Urologic Oncology Center are treated by a multidisciplinary team that closely reviews each case and comes to a consensus about a suggested treatment regimen. The team consists of urology, radiation oncology, medical oncology and a urology nurse navigator.  They provide a high level of care that incorporates evidence-based medicine and the newest protocols in the field. Patients are able to see all of the necessary medical disciplines within a two hour appointment, facilitating their treatment decision. 
 
For more information on The Valley Hospital's Urologic Oncology Center, please call 201-634-5567.

 
News from The Daniel & Gloria Blumenthal Cancer Center
Fusion Guided Biopsy: Diagnosing Prostate Cancer with Pinpoint Accuracy Wed, Sep 13, 2017

There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.

Valley Selected as One of 100 Hospitals and Health Systems with Great Oncology Programs Mon, Sep 11, 2017

Becker’s Hospital Review has once again named The Valley Hospital to its 2017 edition of "100 Hospitals and Health Systems with Great Oncology Programs.” This is the second year in a row that Valley’s Oncology Program has been named to this list.

View all
Contact the Blumenthal Cancer Center

Have a question? Call 201-634-5339 or complete the form below. If you are experiencing a medical emergency, please call your doctor or emergency services provider.

(-